CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Novo Nordisk A/S - share repurchase programme

Neutral
AI Analysis

Summary

Novo Nordisk announced the initiation of a share repurchase programme of up to DKK 15 billion to be executed over a 12-month period beginning February 4, 2026, in accordance with EU regulations.

Importance:2/10
Sentiment:
0.00
share repurchasecapital allocationshareholder returns
Related Companies

Read the original article

Published by GlobeNewswire Pharma on August 17, 2026 12:21 PM

Read Original